Tate & Lyle

Tate & Lyle, a publicly listed company known for producing artificial sweeteners like Splenda, has agreed to a significant takeover deal valued at £2.7 billion. The acquisition is being made by its US competitor, Ingredion. This deal represents a substantial premium to Tate & Lyle's share price prior to the announcement, with the offer set at 615p per share. The news of this takeover is particularly noteworthy as it signifies another high-profile British business potentially moving into foreign ownership, contributing to a trend of overseas bids for UK companies. The transaction could have implications for jobs and marks a notable event for the London stock market. Tate & Lyle's agreement to this acquisition makes it a current focus of financial news due to its scale and the broader context of international M&A activity involving UK-based firms.